Rose Hodgson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rose Hodgson has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Aneesha Bhandari
Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK
2 shared publications- Katherine R. Bull
Nuffield Department of Medicine, University of Oxford, Oxford, UK
2 shared publications - Mukta Deobagkar-Lele
MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK
2 shared publications - Richard J. Cornall
Henry Wellcome Building of Molecular Physiology, University of Oxford, Oxford, UK
2 shared publications - Alberto Cebrian-Serrano
Helmholtz Zentrum München
1 shared publication Benjamin Davies
Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK
1 shared publication
Latest Publications
- 9 August 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 9 (98)
B cells require DOCK8 to elicit and integrate T cell help when antigen is limiting
Dedicator of cytokinesis 8 (DOCK8) immunodeficiency syndrome is characterized by a failure of the germinal center response, a process involving the proliferation and positive selection of antigen-specific B cells. Here, we describe how DOCK8-deficient B cells are blocked at a light-zone checkpoint in the germinal centers of immunized mice, where they are unable to respond to T cell–dependent survival and selection signals and consequently differentiate into plasma cells or memory B cells. Although DOCK8-deficient B cells can acquire and present antigen to initiate activation of cognate T cells, integrin up-regulation, B cell–T cell conjugate formation, and costimulation are insufficient for sustained B cell and T cell activation when antigen availability is limited. Our findings provide an explanation for the failure of the humoral response in DOCK8 immunodeficiency syndrome and insight into how the level of available antigen modulates B cell–T cell cross-talk to fine-tune humoral immune responses and immunological memory.
- 9 August 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 9 (98)
B cells require DOCK8 to elicit and integrate T cell help when antigen is limiting
Dedicator of cytokinesis 8 (DOCK8) immunodeficiency syndrome is characterized by a failure of the germinal center response, a process involving the proliferation and positive selection of antigen-specific B cells. Here, we describe how DOCK8-deficient B cells are blocked at a light-zone checkpoint in the germinal centers of immunized mice, where they are unable to respond to T cell–dependent survival and selection signals and consequently differentiate into plasma cells or memory B cells. Although DOCK8-deficient B cells can acquire and present antigen to initiate activation of cognate T cells, integrin up-regulation, B cell–T cell conjugate formation, and costimulation are insufficient for sustained B cell and T cell activation when antigen availability is limited. Our findings provide an explanation for the failure of the humoral response in DOCK8 immunodeficiency syndrome and insight into how the level of available antigen modulates B cell–T cell cross-talk to fine-tune humoral immune responses and immunological memory.
- Open Access
- 10 November 2022
- Published by Springer Nature in Communications Biology
- Vol. 5 (1) , 1-14
NDRG1 is induced by antigen-receptor signaling but dispensable for B and T cell self-tolerance
Peripheral tolerance prevents the initiation of damaging immune responses by autoreactive lymphocytes. While tolerogenic mechanisms are tightly regulated by antigen-dependent and independent signals, downstream pathways are incompletely understood. N-myc downstream-regulated gene 1 (NDRG1), an anti-cancer therapeutic target, has previously been implicated as a CD4+T cell clonal anergy factor. By RNA-sequencing, we identifiedNdrg1as the third most upregulated gene in anergic, compared to naïve follicular, B cells.Ndrg1is upregulated by B cell receptor activation (signal one) and suppressed by co-stimulation (signal two), suggesting that NDRG1 may be important in B cell tolerance. However, thoughNdrg1−/−mice have a neurological defect mimicking NDRG1-associated Charcot-Marie-Tooth (CMT4d) disease, primary and secondary immune responses were normal. We find that B cell tolerance is maintained, and NDRG1 does not play a role in downstream responses during re-stimulation of in vivo antigen-experienced CD4+T cells, demonstrating that NDGR1 is functionally redundant for lymphocyte anergy.
- 10 November 2022
- Published by Springer Nature in Communications Biology
- Vol. 5 (1) , 1-14
Open AccessNDRG1 is induced by antigen-receptor signaling but dispensable for B and T cell self-tolerance
Peripheral tolerance prevents the initiation of damaging immune responses by autoreactive lymphocytes. While tolerogenic mechanisms are tightly regulated by antigen-dependent and independent signals, downstream pathways are incompletely understood. N-myc downstream-regulated gene 1 (NDRG1), an anti-cancer therapeutic target, has previously been implicated as a CD4+T cell clonal anergy factor. By RNA-sequencing, we identifiedNdrg1as the third most upregulated gene in anergic, compared to naïve follicular, B cells.Ndrg1is upregulated by B cell receptor activation (signal one) and suppressed by co-stimulation (signal two), suggesting that NDRG1 may be important in B cell tolerance. However, thoughNdrg1−/−mice have a neurological defect mimicking NDRG1-associated Charcot-Marie-Tooth (CMT4d) disease, primary and secondary immune responses were normal. We find that B cell tolerance is maintained, and NDRG1 does not play a role in downstream responses during re-stimulation of in vivo antigen-experienced CD4+T cells, demonstrating that NDGR1 is functionally redundant for lymphocyte anergy.